Eye News and Research

Latest Eye News and Research

Simple 20-20-20 rule can help ease some of the symptoms of prolonged computer use

Simple 20-20-20 rule can help ease some of the symptoms of prolonged computer use

Large clinical trial compares four drugs commonly used to treat type 2 diabetes

Large clinical trial compares four drugs commonly used to treat type 2 diabetes

Formula may be right for infants, but experts warn that toddlers don’t need it

Formula may be right for infants, but experts warn that toddlers don’t need it

Study suggests healthcare personnel have a low risk of developing monkeypox when exposed to infected patients

Study suggests healthcare personnel have a low risk of developing monkeypox when exposed to infected patients

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Smartphones can detect blood oxygen saturation levels down to 70%, study shows

Smartphones can detect blood oxygen saturation levels down to 70%, study shows

First multi-center, large-scale registry of severe asthma patients launched in Singapore

First multi-center, large-scale registry of severe asthma patients launched in Singapore

Private equity sees the billions in eye care as firms target high-profit procedures

Private equity sees the billions in eye care as firms target high-profit procedures

Deep AI models fail to capture the configural nature of human shape perception

Deep AI models fail to capture the configural nature of human shape perception

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Winners of the 2022 CURE-19 Research Pilot Grants announced

Winners of the 2022 CURE-19 Research Pilot Grants announced

Scientists identify two distinct subtypes of obesity

Scientists identify two distinct subtypes of obesity

NIH's Bridge2AI program aims to expand use of AI by biomedical and behavioral research communities

NIH's Bridge2AI program aims to expand use of AI by biomedical and behavioral research communities

New technology reveals cellular changes across neural-epithelial-vascular complex in choroideremia

New technology reveals cellular changes across neural-epithelial-vascular complex in choroideremia

Immunotherapy before surgery improves outcomes in many patients with stage II–IV cutaneous squamous cell carcinoma

Immunotherapy before surgery improves outcomes in many patients with stage II–IV cutaneous squamous cell carcinoma

Study reveals recommended levels of long-term blood sugar to avoid diabetes-related damage

Study reveals recommended levels of long-term blood sugar to avoid diabetes-related damage

Neuroscientists reveal precise connections between retinal nerve cells and the midbrain structure

Neuroscientists reveal precise connections between retinal nerve cells and the midbrain structure

Research could lead to a new therapeutic option for patients with bladder cancer

Research could lead to a new therapeutic option for patients with bladder cancer

Study reveals two distinct types of obesity with physiological and molecular differences

Study reveals two distinct types of obesity with physiological and molecular differences

Long COVID linked to persistence of SARS-CoV-2 spike protein in blood

Long COVID linked to persistence of SARS-CoV-2 spike protein in blood

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.